Stallergenes, the world leader in sublingual immunotherapy, has selected
Veeva CRM to replace its existing conventional on-premise systems to support
its worldwide sales force. Veeva CRM is today's #1 selling cloud-based CRM
solution for the global pharmaceutical and biotech industry.
Previously, Stallergenes utilised four different
Customer Relationship Management (CRM) systems across 14 countries before
selecting Veeva CRM. Veeva was chosen
from a pool of CRM vendors to support Stallergenes growing international
operations and new sales force effectiveness initiative. According to the
company, Veeva CRM proved to be the most innovative and robust solution,
enabling improved customer targeting, increased understanding of customer
behaviour and enhanced coordination of data between the field force, medical
affairs and marketing teams.
"We needed a system that could support rapid growth across borders," said Cyril
Tavier,
vice president,
international operations at Stallergenes. "Veeva's cloud-based solution is the
gold standard in new, innovative technologies, allowing the high level of
flexibility and scalability we need to support our expanding operations
globally. Veeva is a perfect match for our company, and supports our mission as
an industry innovator."
Thierry Grehaigne, vice president, information
technologies at Stallergenes added, "We wanted a single, comprehensive CRM
solution that would be intuitive and easy to use for all users across regions
and that could keep pace with changing technology. Veeva had it all."
Stallergenes will also be rolling out Veeva's
leading iPad application, iRep, to users in major European markets. Veeva iRep
is the first integrated CLM/CRM application designed specifically for the Apple
iPad. Veeva redesigned its CRM application to leverage the many strengths of
the iPad and added closed loop marketing functionality to allow seamless
alignment of sales and marketing strategies and execution.
"We are very excited about how iRep will
revolutionise our customer interactions by bringing us closer to our customers
and being able to respond to their specific needs," added Cyril
Tavier. "The integrated CRM and CLM functionality in iRep will allow
our teams to tailor marketing and medical messages to micro-segments of the
market. And, we'll have a constant feedback loop between the field force
and head office."
Over the past four years, Veeva Systems has quickly
become a leading provider of CRM solutions to the global pharmaceutical
industry. Because of its cloud-based platform, Veeva CRM requires no hardware
or software to purchase, scale, or maintain. In addition, all Veeva customers
benefit from free, automatic upgrades so users are always on the most current
version of the software and benefit from the very latest compliance changes and
system enhancements.
"Veeva CRM will play a pivotal role in the speed at
which we develop our international operations and deliver on our new sales
force effectiveness programme," said Cyril Tavier.
"Forward-thinking
pharma companies throughout Europe, like Stallergenes, are realising the value
in replacing limited, on-premise applications with Veeva's flexible cloud-based
enterprise solution." concluded Dan Goldsmith, general manager of Veeva Europe.
"We look forward to working closely with the Stallergenes team as their
commercial enterprise grows."
For more information, visit
www.veevasystems.com
About Stallergenes
Stallergenes is a European biopharmaceutical
company dedicated to the treatment of allergy-related respiratory diseases,
such as severe rhinoconjunctivitis and rhinitis, as well as allergic asthma, using
allergen immunotherapy. The leader in sublingual immunotherapy treatment,
Stallergenes devotes almost 20% of its gross turnover to Research &
Development and is actively involved in the development of a new therapeutic
class, sublingual immunotherapy tablets. In 2010, the company had a turnover of
216 million euros, and more than 500,000 patients were treated with
Stallergenes products.
About Veeva CRM
The Veeva CRM suite of applications, comprised of VBioPharma, iRep, VMobile,
and VInsights, is the pharmaceutical and biotechnology industry's leading
cloud-based CRM solution. In addition, iRep has quickly become the industry's
choice for closed loop marketing on the iPad. Only Veeva CRM accommodates the
unique needs of multiple commercial teams in a single solution, improving user
adoption and sales effectiveness, while reducing cost and complexity. Veeva CRM
is now the foundation on which the pharmaceutical industry is adapting its
sales and marketing models for the future.
About Veeva Systems
Veeva Systems is the leader in cloud-based solutions for the global life
sciences industry. Committed to innovation, product excellence, and customer
success, Veeva has over 100 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a
privately held company headquartered in the San Francisco Bay Area, with
offices in Philadelphia, Barcelona, Budapest, Paris, Beijing, Shanghai, and
Tokyo.